CELZ Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
-100.0%
3.0K
0
Cost of Revenue
0
0
0
-100.0%
994
0
Gross Profit
0
0
0
-100.0%
2.0K
0
Operating Expenses
2.7M
+74.5%
1.6M
+7.1%
1.5M
-25.1%
1.9M
+53.0%
1.3M
R&D
1.6M
+248.8%
459.2K
-15.2%
541.7K
-1.5%
550.1K
+18.3%
465.2K
SG&A
1.1M
+2.6%
1.1M
+21.5%
888.6K
-35.0%
1.4M
+75.9%
776.8K
Operating Income
-2725952
-74.5%
-1562163
-7.1%
-1459153
+25.0%
-1945782
-52.8%
-1273034
EBITDA
-2709299
-76.0%
-1539245
-7.6%
-1430298
+25.3%
-1914833
-54.2%
-1241975
Net Income
-2663478
-76.2%
-1511250
-7.7%
-1403717
+25.6%
-1887674
-52.7%
-1235934
EPS (Basic)
$-0.40
+2.4%
$-0.41
-7.9%
$-0.38
+51.9%
$-0.79
-64.6%
$-0.48
EPS (Diluted)
$-0.40
+2.4%
$-0.41
-7.9%
$-0.38
+51.9%
$-0.79
-64.6%
$-0.48
Shares (Diluted)
6.7M
+80.0%
3.7M
+0.0%
3.7M
+54.9%
2.4M
-7.4%
2.6M
Creative Medical Technology (CELZ) — Financials